Compare Avantis US Small Cap Value ETF (AVUV) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Avantis US Small Cap Value ETF vs Twist Bioscience Corp — how do they compare? Avantis US Small Cap Value ETF trades at $127.58, while Twist Bioscience Corp trades at $125.49 (market cap $7.72B). Which is the better fit depends on your goals.
| AVUV | TWST | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $128.74 | $124.88 |
52-Week Low | $93.93 | $24.16 |
Market Cap | — | $7.72B |
Enterprise Value | — | $7.65B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Avantis US Small Cap Value ETF
AVUV is an actively managed ETF that targets small-cap value companies in the United States. It uses a systematic, rules-based process to identify firms with low valuations and high profitability, aiming to capture the historical premiums of 'size' and 'value' while filtering for financial quality.
Read more on AVUV →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
